Business Development

What are we looking for?

Oncology:

Oncology is currently a growth driver for Pierre Fabre’s pharmaceutical activities through R&D and commercial partnerships with companies developing targeted therapies in oncology (solid and hematologic tumors).
Our areas of interest focus on innovative products ranging from preclinical to late-stage development:
Innovative products targeting sub-populations of patients with solid tumors such as skin cancers, including melanoma, gastrointestinal cancers, women’s cancers, lung cancers, etc.
Targeted therapies aimed at oncogenes or key signaling pathways involved in tumorigenesis and resistance.
We are interested in various therapeutic classes, including small molecules, monoclonal antibodies, and Antibody Drug Conjugates.

Dermatology:

Pierre Fabre is a key player in the field of medical dermatology. As part of our development, three priority therapeutic areas have been defined: onco-dermatology (basal cell carcinoma, squamous cell carcinoma, actinic keratosis, cutaneous lymphomas, supportive care for oncology therapies), rare dermatological diseases (genetic, autoimmune, and inflammatory diseases), and pediatric dermatology (atopic dermatitis, hemangiomas, warts, , etc.).
Our franchise is interested in any drug candidate that has demonstrated clinical proof of concept.

Rare Diseases:

We are looking for partnerships involving innovative treatments, either marketed or in clinical development, that have demonstrated clinical proof of efficacy.
We are interested in various therapeutic classes, including small molecules, monoclonal antibodies, and advanced therapy medicinal products.
Our global footprint enables us to consider partnerships for Europe, the United States, and Asia.

Dermocosmetics:

Our priority is to acquire rights or develop collaborations on innovative ingredients to be integrated into our formulations and supported by clinical evidence.
We are also seeking innovative formulation technologies, packaging solutions, and electronic devices for dermocosmetic applications.

Other Medicines:

Pierre Fabre has a historical portfolio focused on urology, gynecology, and rheumatology.
Urology is a priority area for acquisitions or commercial licensing agreements, primarily within Europe.
We offer to maximize the potential of your products through agreements tailored to your needs, in order to provide therapeutic solutions to patients.
Pierre Fabre’s expertise and reputation also rely on consumer-oriented brands, particularly Naturactive and Pierre Fabre Oral Care, for which we are seeking natural health products and oral care solutions.

Our Business Development team — contact us